These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33262950)
1. Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands. Akbaba S; Bostel T; Lang K; Bahadir S; Lipman D; Schmidberger H; Matthias C; Rotter N; Knopf A; Freudlsperger C; Plinkert P; Debus J; Adeberg S Front Oncol; 2020; 10():593379. PubMed ID: 33262950 [TBL] [Abstract][Full Text] [Related]
2. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience. Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395 [TBL] [Abstract][Full Text] [Related]
3. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx. Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061 [TBL] [Abstract][Full Text] [Related]
4. Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck. Akbaba S; Mock A; Hoerner-Rieber J; Held T; Katayama S; Forster T; Freudlsperger C; Rieken S; Herfarth K; Plinkert P; Debus J; Adeberg S Front Oncol; 2019; 9():755. PubMed ID: 31475108 [No Abstract] [Full Text] [Related]
5. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival. Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145 [TBL] [Abstract][Full Text] [Related]
6. Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience. Akbaba S; Ahmed D; Mock A; Held T; Bahadir S; Lang K; Syed M; Hoerner-Rieber J; Forster T; Federspil P; Herfarth K; Plinkert P; Debus J; Adeberg S Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683896 [TBL] [Abstract][Full Text] [Related]
7. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis. Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089 [TBL] [Abstract][Full Text] [Related]
8. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy. Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774 [TBL] [Abstract][Full Text] [Related]
9. Oncological outcomes of patients with salivary gland cancer treated with surgery and postoperative intensity-modulated radiotherapy: a retrospective cohort study. Zang S; Chen M; Huang H; Zhu X; Li X; Yan D; Yan S Quant Imaging Med Surg; 2022 May; 12(5):2841-2854. PubMed ID: 35502385 [TBL] [Abstract][Full Text] [Related]
10. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation? Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864 [TBL] [Abstract][Full Text] [Related]
11. Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety. Akbaba S; Lang K; Held T; Herfarth K; Rieber J; Plinkert P; Auffarth GU; Rieken S; Debus J; Adeberg S Cancer Manag Res; 2019; 11():1155-1166. PubMed ID: 30774443 [TBL] [Abstract][Full Text] [Related]
12. Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution. Högerle BA; Lasitschka F; Muley T; Bougatf N; Herfarth K; Adeberg S; Eichhorn M; Debus J; Winter H; Rieken S; Uhl M Radiat Oncol; 2019 Jul; 14(1):117. PubMed ID: 31272473 [TBL] [Abstract][Full Text] [Related]
13. Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity. Lang K; Baur M; Akbaba S; Held T; Kargus S; Bougatf N; Bernhardt D; Freier K; Plinkert PK; Rieken S; Debus J; Adeberg S Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518108 [TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognosis analysis of perineural invasion on sinonasal adenoid cystic carcinoma]. Wang ZK; Zhang JH; Chen XS; Liu QF; Wang JB; Wu RY; Zhang Y; Wang K; Qu Y; Huang XD; Xiao JP; Gao L; Xu GZ; Yi JL; Luo JW Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):185-191. PubMed ID: 35184464 [No Abstract] [Full Text] [Related]
15. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center. Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy. Pelak MJ; Walser M; Bachtiary B; Hrbacek J; Lomax AJ; Kliebsch UL; Beer J; Pica A; Malyapa R; Weber DC Oral Oncol; 2020 Aug; 107():104752. PubMed ID: 32413727 [TBL] [Abstract][Full Text] [Related]
17. Definitive carbon ion radiotherapy for tracheobronchial adenoid cystic carcinoma: a preliminary report. Chen J; Mao J; Ma N; Wu KL; Lu J; Jiang GL BMC Cancer; 2021 Jun; 21(1):734. PubMed ID: 34174854 [TBL] [Abstract][Full Text] [Related]
18. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial. Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022 [TBL] [Abstract][Full Text] [Related]
19. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy. Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197 [TBL] [Abstract][Full Text] [Related]
20. [Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy]. Wang JB; Jiang W; Ji Z; Cao JZ; Liu LP; Men Y; Xu C; Wang XZ; Hui ZG; Liang J; Lyu JM; Zhou ZM; Xiao ZF; Feng QF; Chen DF; Zhang HX; Yin WB; Wang LH Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):607-14. PubMed ID: 27531481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]